Furthermore, miR-181a-5p promoted cell proliferation, invasion and glycolysis of breast cancer by targeting NDRG2 via the PTEN/AKT pathway, suggesting that miR-181a-5p may be a potential target for breast cancer therapy. The gene discussed is NDRG2; the disease is breast carcinoma.